{
    "code": "01017007",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01017007",
    "time": "2021-10-01 03:01:45",
    "許可證字號": "衛署藥製字第017007號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/03\/21",
    "發證日期": "68\/03\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00101700705",
    "中文品名": "西華樂林注射劑０．５公克",
    "英文品名": "CEFAZOLIN INJECTION 0.5GM &quot;C.C.P.&quot;",
    "適應症": "有感受性的葡萄球菌、鏈鎖球菌、肺炎球菌、大腸菌、肺炎桿菌、變形菌等病原菌所引起之感染症",
    "劑型": "270注射劑",
    "包裝": "0.5公克小瓶裝，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CEFAZOLIN (SODIUM)",
    "限制項目": "01國　產",
    "申請商名稱": "6141141199  中國化學製藥股份有限公司台南三廠",
    "申請商地址": "台南市官田區二鎮里工業西路46號之8",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812309510",
            "成分名稱": "CEFAZOLIN (SODIUM)",
            "含量描述": "0.5",
            "含量": "0.5000000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "Cefazolin 0.5gm In-105-06-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01017007&Seq=002&Type=9"
        },
        {
            "title": "Cefazolin 0.5mg La(1V)-105-06-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01017007&Seq=005&Type=8"
        }
    ]
}